PT1664061T - Processo para a síntese de compostos de morfinano e seus intermediários - Google Patents

Processo para a síntese de compostos de morfinano e seus intermediários

Info

Publication number
PT1664061T
PT1664061T PT47613328T PT04761332T PT1664061T PT 1664061 T PT1664061 T PT 1664061T PT 47613328 T PT47613328 T PT 47613328T PT 04761332 T PT04761332 T PT 04761332T PT 1664061 T PT1664061 T PT 1664061T
Authority
PT
Portugal
Prior art keywords
intermediates
synthesis
morphinane compounds
morphinane
compounds
Prior art date
Application number
PT47613328T
Other languages
English (en)
Inventor
Smith Craig
Purcell Stuart
Waddell Lucy
Hayes Nicholas
Ritchie Jarrod
Brian Halliday Scott
Mitchell Melville
Scott Wilson George
Original Assignee
Glaxosmithkline Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003905153A external-priority patent/AU2003905153A0/en
Application filed by Glaxosmithkline Australia Pty Ltd filed Critical Glaxosmithkline Australia Pty Ltd
Publication of PT1664061T publication Critical patent/PT1664061T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT47613328T 2003-09-22 2004-09-22 Processo para a síntese de compostos de morfinano e seus intermediários PT1664061T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2003905153A AU2003905153A0 (en) 2003-09-22 Chemical Compounds and Processes

Publications (1)

Publication Number Publication Date
PT1664061T true PT1664061T (pt) 2017-06-22

Family

ID=34318304

Family Applications (1)

Application Number Title Priority Date Filing Date
PT47613328T PT1664061T (pt) 2003-09-22 2004-09-22 Processo para a síntese de compostos de morfinano e seus intermediários

Country Status (7)

Country Link
EP (1) EP1664061B1 (pt)
JP (1) JP4879740B2 (pt)
CA (1) CA2539659C (pt)
ES (1) ES2627995T3 (pt)
HU (1) HUE034668T2 (pt)
PT (1) PT1664061T (pt)
WO (1) WO2005028483A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2073636T3 (da) 2006-10-17 2012-11-19 Penick Corp Fremgangsmåde til fremstilling af oxymorphon
CA2674915C (en) * 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
GB0624880D0 (en) 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
PL2125824T5 (pl) 2007-03-23 2024-11-04 SpecGx LLC Ulepszony sposób wytwarzania oksymorfonu z oripawiny
WO2008130553A1 (en) 2007-04-16 2008-10-30 Mallinckrodt Inc. Novel opiate reduction utilizing catalytic hydrogen transfer reaction
WO2009067275A1 (en) * 2007-11-21 2009-05-28 Progenics Pharmaceuticals, Inc N-oxides of 4,5-epoxy-morphinanium analogs
CN102089310A (zh) * 2008-06-20 2011-06-08 Tpi企业有限公司 用于合成n-去甲基吗啡烷化合物的方法
CN102325777B (zh) 2009-02-23 2015-08-12 马林克罗特公司 (+)-吗啡喃*n-氧化物及其制备方法
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
BR112013003097B1 (pt) * 2010-08-12 2021-03-16 Boehringer Ingelheim International Gmbh 6-cicloalquil-pirazolopirimidinonas e composição farmacêutica
EP2705043B1 (en) * 2011-05-02 2016-11-30 Brock University Processes and intermediates in the preparation of morphine analogs via n-demethylation of n-oxides using cyclodehydration reagents
JP6121988B2 (ja) 2011-05-06 2017-04-26 ブロック ユニバーシティ 金属触媒ｎ−脱メチル化／官能基化および分子内基移動によるモルヒネ類似体の調製のための方法
KR20140063763A (ko) 2011-09-08 2014-05-27 말린크로트 엘엘씨 중간체를 단리하지 않는 알칼로이드의 제조 방법
WO2013113120A1 (en) * 2012-02-03 2013-08-08 Tomas Hudlicky Process for the preparation of morphine analogs via the reaction of organometallic reagents with an oxazolidine derived from morphinans
EP3027622B8 (en) 2013-08-02 2019-06-12 Johnson Matthey Public Limited Company Process for the preparation of oxymorphone
GB201313915D0 (en) 2013-08-02 2013-09-18 Johnson Matthey Plc Process
US20160052932A1 (en) 2014-08-25 2016-02-25 Johnson Matthey Public Limited Company Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB939287A (en) * 1961-03-14 1963-10-09 Sankyo Co New morphinone and codeinone derivatives and process for preparing the same
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
AUPQ968300A0 (en) * 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods

Also Published As

Publication number Publication date
CA2539659A1 (en) 2005-03-31
EP1664061A4 (en) 2009-09-09
ES2627995T3 (es) 2017-08-01
JP2007505935A (ja) 2007-03-15
EP1664061B1 (en) 2017-03-15
HUE034668T2 (hu) 2018-02-28
JP4879740B2 (ja) 2012-02-22
EP1664061A1 (en) 2006-06-07
CA2539659C (en) 2013-03-26
WO2005028483A1 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
PT1644384E (pt) Processo e intermediários para a síntese de entecavir
TWI350831B (en) Process for the preparation of ring compounds
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
HUP0500851A3 (en) Process for the preparation of rosuvastatin
PL1651622T3 (pl) Sposób wytwarzania związków 2-(chinoksalin-5-ylosulfonyloamino)benzamidowych
IL223579A0 (en) Synthesis of amines and intermediates for the synthesis thereof
IL167426A (en) Process for the manufacture of valsartan
PL1807395T3 (pl) Sposób syntezy n-alkoksyamin
GB0623764D0 (en) Process for the synthesis of hydromorphone
SI1403264T1 (en) Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester
IL180513A0 (en) Process for synthesis of 4-4'-diamino-diphenyl-sulfone
ZA200601991B (en) Process for the preparation of renzapride and intermediates thereof
TWI347945B (en) Process for the preparation of thiazolopyrimidines
AU2003242867A8 (en) Process for the synthesis of mosapride
AU2003246098A8 (en) Oxamidination process of carbonyl compounds
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
PL1622926T3 (pl) Nowy sposób i produkty pośrednie wytwarzania związków 19-norsteroidów fluorowcowanych w pozycji 17
IL173887A0 (en) A process for the preparation of cilostazol and of the intermediates thereof
IL164788A0 (en) Process for the preparation of 3-isochromanone
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
AU2002360409A8 (en) Methods and intermediates for the synthesis of azepines
PL375437A1 (en) Synthesis of gatifloxacin
ZA200509495B (en) Process for the preparation of nicotinaldehydes
IL163778A0 (en) Processes for the synthesis of chloroadenosine andmethylthioadenosine